CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.050
-0.010 (-0.94%)
Mar 16, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
CBU Service & Related Therapy
69.50K----
Immune Cell Therapy
--1.00113.84K59.47K
Immune Cell Therapy Growth
---100.00%91.43%-
Total
69.50K-1.00113.84K59.47K
Total Growth
---100.00%91.43%-
Source: S&P Global Market Intelligence.